Abstract
Why are not all eligible chronic myeloid leukemia patients willing to attempt tyrosine kinase inhibitor discontinuation? A Czech nationwide analysis related to the TKI stopping trial HALF
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have